Last reviewed · How we verify
NCT07133620
the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery
NA trial testing Transcutaneous electrical acupoint stimulation in Postoperative Gastrointestinal Dysfunction (POGD) in 112 participants. Not yet recruiting.
1 September 2026
Quick facts
| Lead sponsor | The First Affiliated Hospital of Xiamen University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 112 |
| Start date | 1 September 2025 |
| Primary completion | 1 September 2026 |
| Estimated completion | 30 September 2026 |
Drugs / interventions tested
- Transcutaneous electrical acupoint stimulation
- Sham transcutaneous Electrical Acupoint Stimulation
Conditions studied
- Postoperative Gastrointestinal Dysfunction (POGD) — all drugs for Postoperative Gastrointestinal Dysfunction (POGD) →
Sponsor
The First Affiliated Hospital of Xiamen University
Who can join
18 and older, any sex, with Postoperative Gastrointestinal Dysfunction (POGD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this clinical trial is to understand the effect of percutaneous acupoint electrical stimulation on postoperative gastrointestinal dysfunction. It will also investigate the safety of percutaneous acupoint electrical stimulation. The main questions that this trial aims to answer are: Can percutaneous acupoint electrical stimulation alleviate postoperative gastrointestinal dysfunction? Through which mechanisms do they function? Participants will: Preoperatively, patients were either given or not given percutaneous acupoint electrical stimulation. Record their symptoms and biological indicators within 5 days after the operation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07133620
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcutaneous electrical acupoint stimulation
Trials testing the same drug.
- NCT07117123 — Transcutaneous Electrical Acupoint Stimulation on Postoperative Pharyngeal Pain · NA · not yet recruiting
- NCT06772961 — Effect of Percutaneous Electrical Acupoint Stimulation on the Improvement of Incidence of Adverse Respiratory Events · NA · recruiting
- NCT06188286 — The Effect of Patient-Controlled TEAS vs Sham TEAS for Improve Quality of Life in Patients With Cancer Pain · NA · not yet recruiting
- NCT06718231 — TAES Alleviate Post-VATS Depression · NA · not yet recruiting
- NCT06730776 — Effect of Transcutaneous Electrical Acupoint Stimulation on Dyspareunia · NA · not yet recruiting
Other The First Affiliated Hospital of Xiamen University trials
Trials by the same sponsor.
- NCT06875063 — GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL · Phase 1 · recruiting
- NCT07486492 — Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer · EARLY_PHASE1 · not yet recruiting
- NCT07458906 — DLL3-Targeted PET/CT in Neuroendocrine Carcinoma · NA · recruiting
- NCT07137052 — Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar · not yet recruiting
- NCT07189884 — Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07133620 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Xiamen University
- Last refreshed: 21 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07133620.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing